DR. COUNDE OUYANG
Dr Ouyang has had over 35 years of experience in drug discovery. From 2013 to 2018, he was with Novartis Institutes for BioMedical Research (China) where he served as Head of Global Discovery Chemistry (China) and managed chemistry portfolio in drug and target discovery for various disease areas. From 2010 to 2013, he was with Bioduro (a CRO company) where he served as Vice President of Chemistry. At Bioduro, he oversaw all programs in synthetic chemistry, medicinal chemistry and provided integrated services to clients. From 1982 to 2010, Counde worked at Roche – Palo Alto and Syntex (acquired by Roche) where he served in roles of increasing responsibility including Director of Medicinal Chemistry. At Roche, he led multiple small molecule programs that advanced to the clinic. Dr Ouyang is an author on over 60 publications and patents.
Dr Ouyang obtained his Ph.D in Chemistry from Loyola University of Chicago (with Professor James W. Wilt) and pursued postdoctoral research at Massachusetts Institute of Technology (with Professor Frederick D. Greene) and the University of Chicago (with Professor Josef Fried).